SICK at a glance
IFRS figures for the SICK Group
| 2018 | 2019 | 2020 | 2021 | 2022 | |
Net sales (in millions of euros) | 1,636.8 | 1,750.7 | 1,700.2 | 1,964 | 2.189,8 |
| EBIT (in millions of euros) | 117.5 | 132.9 | 140.6 | 202.3 | 164,6 |
| Annual yield (in millions of euros) | 81.7 | 93.9 | 101.1 | 147.8 | 119,5 |
| Cash flow (in millions of euros) | 20.2 | 212.7 | 227.7 | 231.1 | 55,0 |
| Employees as of December 31 | 9,737 | 10,204 | 10,433 | 11,022 | 11.909 |
| R&D expenditure (in millions of euros) | 192.5 | 202.0 | 201.1 | 210.3 | 240,8 |
| Earnings per share (in EUR) | 3.12 | 3.58 | 3.86 | 5.64 | 4,56 |